Literature DB >> 17191351

Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.

George J Brewer1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17191351     DOI: 10.2310/6650.2006.05030

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


× No keyword cloud information.
  3 in total

1.  The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery.

Authors:  Johan Weigelt
Journal:  EMBO Rep       Date:  2009-09       Impact factor: 8.807

2.  Insurance companies' perspectives on the orphan drug pipeline.

Authors:  Robert Handfield; Josh Feldstein
Journal:  Am Health Drug Benefits       Date:  2013-11

3.  Orphan drug: Development trends and strategies.

Authors:  Aarti Sharma; Abraham Jacob; Manas Tandon; Dushyant Kumar
Journal:  J Pharm Bioallied Sci       Date:  2010-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.